INmune Bio 2023 Q4 Earnings Report
Source: iQoncept / Shutterstock
The Financial Misstep of INmune Bio
INmune Bio (NASDAQ:INMB) recently unveiled its financial performance for the final quarter of 2023:
- Reported earnings per share stood at -47 cents, falling short of the projected -44 cents.
- Revenue figures showed $28,000, a notable 30% dip compared to the anticipated $40,000.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/inmb-stock-earnings-inmune-bio-for-q4-of-2023/.
©2024 InvestorPlace Media, LLC
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
